🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

4D Duke Microscope Integrated Optical Coherence Tomography in a Zeiss Artevo 800

RecruitingNAAges 18 Years - anyAllDuke University
NCT07024719 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study team will conduct the first in-human pilot studies using 4D MIOCT for imaging in the operating room. Building on the earlier integration and wet-lab validations, the researchers will assess the system's ease of use, safety, and visualization of intended structures during various anterior and posterior segment ophthalmic procedures.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adult participants 18 years of age and older * Patients undergoing surgery for ocular disease * Adults able and willing to give informed consent to participate in the study Exclusion Criteria: * Patients with any ocular disease that restricts the ability to perform OCT scanning
💊

What it tests

  • 4D MIOCT integrated into a Zeiss Artevo 800
📍

Where

1 site
Duke University Eye Center
Durham, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy